NCT05531214

Creating A Cardiorenal Multidisciplinary Team for Management HF and CKD Patients

Completed NA Last updated 26 August 2024

What this trial tests

NA trial testing Multidisciplinary Care Coordination Team in Heart Failure in 96 participants. Completed in 1 June 2024.

Timeline

1 June 2022

Primary endpoint
30 January 2023

1 June 2024

Quick facts

Lead sponsor	George Washington University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	96
Start date	1 June 2022
Primary completion	30 January 2023
Estimated completion	1 June 2024
Sites	1 location across United States

Drugs / interventions tested

• Multidisciplinary Care Coordination Team

Conditions studied

• Heart Failure — all drugs for Heart Failure →
• Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →

Sponsor

George Washington University

Who can join

18 and older, any sex, with Heart Failure or Chronic Kidney Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Several drugs have been labeled as guideline-directed-medical therapies (GDMT) to improve overall health outcomes and slow the progression of disease in patients with heart failure (HF). Although scientific trials have deemed these drugs to be successful, many HF patients have been unable to either get started on the appropriate drug regimens or be optimized on the doses required to show substantial benefit, particularly in those who also suffer from chronic kidney disease (CKD). This is largely due to the current health care delivery model that requires a primary care clinician or general internist to refer patients to heart failure specialists and nephrologists. The specialty care itself then requires even more coordination resulting in patients getting lost to follow-up, physicians losing track of recommendations from different clinics, and too many separate electronic medical documentations to consolidate prior to deciding on what medication is appropriate at one thirty-minute outpatient visit. This study plans to create a new, virtual cardio-renal multidisciplinary team including a heart failure specialist and nephrologist to ease the coordination of care and consequently show a better implementation of GDMT in patients with HF and CKD when comparing those rates to the traditional referral-based way that these medications get prescribed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.